Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review
- PMID: 38672721
- PMCID: PMC11050889
- DOI: 10.3390/life14040450
Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review
Abstract
This review focuses on ablative techniques for small renal masses (SRMs), including radiofrequency ablation (RFA), cryoablation (CA), microwave ablation (MWA), and irreversible electroporation (IRE), and discusses recurrence management. Through an extensive literature review, we outline the procedures, outcomes, and follow-up strategies associated with each ablative method. The review provides a detailed examination of these techniques-RFA, CA, MWA, and IRE-elucidating their respective outcomes. Recurrence rates vary among them, with RFA and CA showing comparable rates, MWA demonstrating favorable short-term results, and IRE exhibiting promise in experimental stages. For managing recurrences, various strategies are considered, including active surveillance, re-ablation, or salvage surgery. Surveillance is preferred post-RFA and post-CA, due to slow SRM growth, while re-ablation, particularly with RFA and CA, is deemed feasible without additional complications. Salvage surgery emerges as a viable option for larger or resistant tumors. While ablative techniques offer short-term results comparable to surgery, further research is essential to understand their long-term effects fully. Decisions concerning recurrence management should consider individual and tumor-specific factors. Imaging, notably contrast-enhanced ultrasounds, plays a pivotal role in assessing treatment success, emphasizing the necessity of a multidisciplinary approach for optimal outcomes. The lack of randomized trials highlights the need for further research.
Keywords: RCC; ablative techniques; recurrence; small renal masses.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Ljungberg B., Albiges L., Abu-Ghanem Y., Bedke J., Capitanio U., Dabestani S., Fernández-Pello S., Giles R.H., Hofmann F., Hora M., et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur. Urol. 2022;82:399–410. doi: 10.1016/j.eururo.2022.03.006. - DOI - PubMed
-
- Calace F.P., Napolitano L., Arcaniolo D., Stizzo M., Barone B., Crocetto F., Olivetta M., Amicuzi U., Cirillo L., Rubinacci A., et al. Micro-Ultrasound in the Diagnosis and Staging of Prostate and Bladder Cancer: A Comprehensive Review. Medicina. 2022;58:1624. doi: 10.3390/medicina58111624. - DOI - PMC - PubMed
-
- Lasorsa F., Rutigliano M., Milella M., Ferro M., Pandolfo S.D., Crocetto F., Simone S., Gesualdo L., Battaglia M., Ditonno P., et al. Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma. Int. J. Mol. Sci. 2023;24:16515. doi: 10.3390/ijms242216515. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources